Product Information
VESTURA 3 MG-0.02 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1909 per EA under NDC 00480400062. Its NADAC has been published 93 times since Dec 25, 2024.
FDA first approved this application on Nov 28, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480400062
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA078833FDA Approved
11/28/2011
TE Code
AB
On Market Since
11/6/2024
Price Statistics
The NADAC for VESTURA 3 MG-0.02 MG TABLET has been published 93 times since Dec 25, 2024, and over the history we have for it it has risen 26.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1909 per EA |
|---|---|
| All-time high | $0.1933 (Aug 12, 2026) |
| All-time low | $0.1423 (Jan 22, 2025) |
| 52-week high | $0.1933 |
| 52-week low | $0.1538 |
| Median price | $0.1595 |
| Average price | $0.1640 |
| Largest weekly change | +8.5% (May 20, 2026) |
| Weeks tracked | 93 |
| Tracking since | Dec 25, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Drospirenone and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VESTURA 3 MG-0.02 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VESTURA 3 MG-0.02 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1909 per EA (NDC 00480400062), effective Sep 30, 2026.
How has the price of VESTURA 3 MG-0.02 MG TABLET changed over time?
Over the history we have for it, the NADAC for VESTURA 3 MG-0.02 MG TABLET has risen 26.4%. It has been tracked across 93 weekly CMS publications since Dec 25, 2024.
What are the highest and lowest recorded NADAC prices for VESTURA 3 MG-0.02 MG TABLET?
Since Dec 25, 2024, the NADAC for VESTURA 3 MG-0.02 MG TABLET has ranged from a low of $0.1423 (Jan 22, 2025) to a high of $0.1933 (Aug 12, 2026), with a median of $0.1595 per EA.
Are there cheaper alternatives to VESTURA 3 MG-0.02 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZUMANDIMINE 3 MG-0.03 MG TAB, is $0.1511 per EA — about 21% below VESTURA 3 MG-0.02 MG TABLET.
Who manufactures VESTURA 3 MG-0.02 MG TABLET?
VESTURA 3 MG-0.02 MG TABLET (NDC 00480400062) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.